Neuraxis, Inc. (NRXS) - Form 8-K Summary
Business Context and Reporting Period
Neuraxis, Inc., an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on April 21, 2026. The filing provides preliminary, unaudited financial results for the three months ended March 31, 2026.
Key Financial Metrics
| Metric | Three Months Ended March 31, 2026 (Preliminary) | Three Months Ended March 31, 2025 |
|---|---|---|
| Net Sales | $1.6 million | $0.9 million |
| Gross Profit | $1.4 million | Not provided |
| Operating Loss | $1.7 million | Not provided |
| Cash and Cash Equivalents | $7.1 million (as of March 31, 2026) | Not provided |
The filing does not provide specific data on debt, liquidity ratios beyond cash balances, or net income/loss figures.
Material Changes
- Revenue Growth: Net sales increased from approximately $0.9 million in the prior year period to $1.6 million, representing a significant year-over-year increase.
- Profitability: Despite revenue growth, the company reported a preliminary operating loss of $1.7 million for the quarter.
Outlook, Risks, and Management Commentary
Management emphasizes that these figures are preliminary and unaudited. The final financial statements are expected to be completed subsequent to this filing. The company notes that significant judgments made during the quarter-end close process may result in final reported amounts differing from these estimates. The independent registered public accounting firm has not audited or reviewed these preliminary figures, and no assurance is expressed regarding them. Investors are cautioned against placing undue reliance on these estimates as material adjustments could occur.
Investor Verification Checklist
- Verify the final audited financial statements for the quarter ended March 31, 2026, once released.
- Confirm the final cash balance and any changes in debt obligations not detailed in this preliminary report.
- Review the upcoming 10-Q filing for detailed breakdowns of operating expenses contributing to the $1.7 million operating loss.
- Monitor for any material adjustments to the preliminary revenue and gross profit figures.